Roche diagnostic department made sales of over 27billion AUD in 2021. Currently doing some research to find their cost and breakdown of revenue of their equivalent CA15.3 test. Well probably shouldn't say equivalent because Inoviq's SubB2M enhanced CA15.3 breast cancer test is clearly superior.
Ann: Positive results for SubB2M Breast Cancer Test, page-19
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
0.005(0.92%) |
Mkt cap ! $60.92M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 56.5¢ | 55.0¢ | $15.12K | 26.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13918 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 15.16pm 06/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |